Imagen de Portada

Knowledge-accelerated drug development

Guardado en:
Publicado en:Pharmaceutical Executive vol. 18, no. 4 (Apr 1998), p. 88-93
Autor principal: Mamelok, Richard D
Otros Autores: Olson, Camilla
Publicado:
MultiMedia Healthcare Inc.
Materias:
United States > US
Clinical trials
Decision making
Methods
Guidelines
FDA approval
Project management
Pharmaceutical industry
Compliance
Computer based modeling
Research & development > R&D
Critical path
Portfolio management
Software
Teams
Planning
Knowledge
Cholesterol
Design
Drug dosages
Designers
Drug development
Acceso en línea:Citation/Abstract
Full Text
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Resumen:Knowledge-accelerated drug development is a step-by-step process that companies can adopt to take full advantage of state-of-the-art computer-assisted technology. At an operational level within projects, research teams can use knowledge-accelerated drug development to assess different trial designs by accounting for many more variables that affect outcome than traditional methods can accomplish. That allows the team to choose the best design. Moving from current clinical planning methodology to new technology that provides better assessments can occur in 4 sequential steps: 1. computer-based trials management, 2. computer-assisted trial design, 3. computer-assisted clinical program design, and 4. computer-assisted portfolio management.
ISSN:0279-6570
2150-735X
Fuente:ABI/INFORM Global